[go: up one dir, main page]

AU2670897A - Fibulin pharmaceutical compositions and related methods - Google Patents

Fibulin pharmaceutical compositions and related methods

Info

Publication number
AU2670897A
AU2670897A AU26708/97A AU2670897A AU2670897A AU 2670897 A AU2670897 A AU 2670897A AU 26708/97 A AU26708/97 A AU 26708/97A AU 2670897 A AU2670897 A AU 2670897A AU 2670897 A AU2670897 A AU 2670897A
Authority
AU
Australia
Prior art keywords
fibulin
pharmaceutical compositions
related methods
methods
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU26708/97A
Inventor
Larry G. Bennett
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Inc
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of AU2670897A publication Critical patent/AU2670897A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU26708/97A 1996-04-04 1997-04-03 Fibulin pharmaceutical compositions and related methods Abandoned AU2670897A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US62763696A 1996-04-04 1996-04-04
US08627636 1996-04-04
PCT/US1997/006280 WO1997038014A1 (en) 1996-04-04 1997-04-03 Fibulin pharmaceutical compositions and related methods

Publications (1)

Publication Number Publication Date
AU2670897A true AU2670897A (en) 1997-10-29

Family

ID=24515462

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26708/97A Abandoned AU2670897A (en) 1996-04-04 1997-04-03 Fibulin pharmaceutical compositions and related methods

Country Status (2)

Country Link
AU (1) AU2670897A (en)
WO (1) WO1997038014A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001968A (en) * 1994-08-17 1999-12-14 The Rockefeller University OB polypeptides, modified forms and compositions
DE69921486T2 (en) * 1998-08-10 2006-02-02 Amgen Inc., Thousand Oaks DEXTRAN-LEPTIN CONJUGATES, PHARMACEUTICAL COMPOSITIONS AND ASSOCIATED METHODS
US6420339B1 (en) 1998-10-14 2002-07-16 Amgen Inc. Site-directed dual pegylation of proteins for improved bioactivity and biocompatibility
US8106098B2 (en) 1999-08-09 2012-01-31 The General Hospital Corporation Protein conjugates with a water-soluble biocompatible, biodegradable polymer
WO2001089548A2 (en) * 2000-05-24 2001-11-29 Schering Aktiengesellschaft Pharmaceutical use of fibulin-1
WO2002072138A1 (en) * 2001-03-08 2002-09-19 Hyseq, Inc. Methods and materials relating to fibulin-like polypeptides and polynucleotides
SI2219031T1 (en) 2001-10-22 2013-11-29 Amgen, Inc. Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment
EP2286837A3 (en) 2004-11-01 2013-09-04 Amylin Pharmaceuticals, LLC Treatment of obesity and obesity related diseases
US8394765B2 (en) 2004-11-01 2013-03-12 Amylin Pharmaceuticals Llc Methods of treating obesity with two different anti-obesity agents
JP2011500856A (en) * 2007-10-31 2011-01-06 シーアールシー フォー アズマ アンド エアウェイズ エルティーディー Methods and compositions for modulating airway tissue remodeling
WO2009149379A2 (en) 2008-06-05 2009-12-10 Regents Of The University Of Michigan Use of leptin for the treatment of fatty liver diseases and conditions
JP6174489B2 (en) 2010-09-28 2017-08-02 アエゲリオン ファーマシューティカルズ，インコーポレイテッド Highly soluble leptin
HUE040496T2 (en) 2012-09-27 2019-03-28 Childrens Medical Ct Corp Compounds for the treatment of obesity and their application procedures
JP6672157B2 (en) 2013-11-26 2020-03-25 ザ チルドレンズ メディカル センター コーポレーション Compounds for treating obesity and methods of using the same
WO2015153933A1 (en) 2014-04-03 2015-10-08 The Children's Medical Center Corporation Hsp90 inhibitors for the treatment of obesity and methods of use thereof
HRP20231076T1 (en) 2016-09-12 2023-12-22 Amryt Pharmaceuticals Inc. Methods of detecting anti-leptin neutralizing antibodies

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0484452A1 (en) * 1989-08-18 1992-05-13 La Jolla Cancer Research Foundation Fibulin

Also Published As

Publication number Publication date
WO1997038014A1 (en) 1997-10-16

Similar Documents

Publication Publication Date Title
AU3767097A (en) Shampoo compositions and method
AU5081298A (en) Surgical method and composition therefor
AU3641597A (en) Methods and compositions comprising r-ibuprofen
AU3049397A (en) Cyclosporin-containing pharmaceutical composition
AU4762797A (en) Pharmaceutical compositions
AU2967597A (en) Pharmaceutical compositions
AU2075997A (en) Orally-administered interferon-tau compositions and methods
HUP9900424A2 (en) Thiazolylbenzofuran derivatives and pharmaceutical compositions containing them
AU2972597A (en) Compositions and uses thereof
AU5856898A (en) Heteroarylsulfonamide derivatives and pharmaceutical compositions containing them
AU1731997A (en) Antipathogenic peptides and compositions comprising them
AU5565099A (en) Pharmaceutical compositions and methods for use
AU4083997A (en) Gata-6 transcription factor: compositions and methods
AU2670897A (en) Fibulin pharmaceutical compositions and related methods
AU3777897A (en) Pharmaceutical compositions
AU4326197A (en) Pharmaceutical compositions
AU3304097A (en) Water-based makeup compositions and methods for their preparation
AU4876397A (en) Insecticidal compositions and methods
HUP0000460A3 (en) Imidazopyridazines and pharmaceutical compositions thereof
AU3200197A (en) New composition and methods
AU3460897A (en) Medicinal compositions
AU5125698A (en) Stabilized pharmaceutical compositions based on quinupristine and on dalfopristine and their preparation
AU3354797A (en) Novel anticoagulant glycosides and pharmaceutical compositions thereof
AUPO982097A0 (en) Methods and compositions for use therein
AU2171297A (en) Pharmaceutical compositions and methods for the manufacture thereof